{{NoteTA|G1=Medicine}}
{{PBB|geneid=1576}}
'''细胞色素P450 3A4酶'''（{{lang-en|Cytochrome P450 3A4}}，'''CYP3A4'''）（{{EC number|1.14.13.97}}）是身体中的一种重要的[[酶|酶]]，主要存在于[[肝脏|肝脏]]和[[小肠|小肠]]。它可以[[氧化|氧化]]外源有机小分子（异生素<ref>https://www.termonline.cn/word/101700/1</ref>，xenobiotics），如[[毒素|毒素]]或[[药物|药物]]，以便使其排出体外。

CYP3A4会使许多药物失活，但同时它也使一些药物活性增加。一些物质，诸如葡萄柚汁和某些药物，会被CYP3A4的作用所干扰。这些物质将增强或减弱药物的作用，由于CYP3A4的干扰作用。

CYP3A4是细胞色素P450氧化酶家族成员之一。这个家族中的若干其它成员也涉及到药物的代谢，但CYP3A4是最常见和最多面的一个。与该家族所有成员类似，CYP3A4是一种[[血红蛋白|血红蛋白]]——一种含有附带了一个[[铁|铁]]原子的[[血红素|血红素]]基团的[[蛋白质|蛋白质]]。对[[人类|人类]]而言，CYP3A4蛋白由CYP3A4基因所编码<ref name="pmid8269949">{{cite journal|author=Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T|title= Gene structure of CYP3A4, an adult-specific form of cytochrome P<sub>450</sub> in human livers, and its transcriptional control| journal = Eur. J. Biochem.|volume=218|issue=2|pages=585-95|date=December 1993|pmid=8269949|doi=10.1111/j.1432-1033.1993.tb18412.x}}</ref>。这个基因是[[细胞色素|细胞色素]]P450[[基因簇|基因簇]]的一部分，位于人类的[[7号染色体|7号染色体]]长臂2区1带1子带（chromosome 7q21.1）上<ref name="pmid1391968">{{cite journal|author=Inoue K, Inazawa J, Nakagawa H, Shimada T, Yamazaki H, Guengerich FP, Abe T|title=Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization|journal=Jpn. J. Hum. Genet.|volume=37|issue=2|pages=133-8|date=June 1992|pmid=1391968|doi=10.1007/BF01899734}}</ref>。

'''rCYP3A4'''（重组CYP3A4，recombinant CYP3A4）是通过[[基因工程|基因工程]]合成的CYP3A4蛋白。

==功能==
CYP3A4是细胞色素P450超家族酶类中的一员。细胞色素P450蛋白质是[[单氧酶|单氧酶]]类，可以催化涉及[[药物代谢|药物代谢]]以及胆固醇、类固醇和其它脂类成分的合成的众多反应。

CYP3A4蛋白位于[[细胞|细胞]]的[[内质网|内质网]]（{{lang-en|endoplasmic reticulum}}）中，其表达受[[糖皮质激素|糖皮质激素]]（{{lang-en|glucocorticoid}}）和一些药物试剂的诱导。该酶参与了现今使用的近半数药物的代谢，其中包括[[对乙酰氨基酚|对乙酰氨基酚]]（{{lang-en|acetaminophen}}）、[[可待因|可待因]]（{{lang-en|codeine}}）、[[环孢菌素|环孢菌素]]（{{lang-en|ciclosporin/cyclosporin}}）、[[地西泮|地西泮]]（{{lang-en|diazepam}}）和[[红霉素|红霉素]]（{{lang-en|erythromycin}}）。<ref name="entrez">{{cite web| title = Entrez Gene: cytochrome P450| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1576| accessdate = | archive-date = 2010-12-05| archive-url = https://web.archive.org/web/20101205081110/http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene| dead-url = no}}</ref> 大部分药物经过CYP3A4的钝化作用，或直接或有利于促进了药物从机体的排泄作用。同样地，许多药品经由CYP3A4活化而形成其活性成分，而许多原毒素也由此成为其毒性形式。

==蛋白转换==
人类的CYP3A4蛋白转换率变化范围很大。 对于[[肝脏|肝脏]]部分的CYP3A4蛋白，[[体内|体内]]方法估计该酶[[生物半衰期|生物半衰期]]（{{lang-en|half-life}}）主要在70到140个小时；[[体外|体外]]方法大概在26到79个小时。<ref name = "Yang"/> [[肠道|肠道]]CYP3A4蛋白的转换很可能类似于[[肠上皮细胞|肠上皮细胞]]（{{lang-en|enterocyte}}）的更新率；一种非直接的方法，基于暴露于葡萄柚汁后的活性恢复，其测量结果在12到33个小时。<ref name = "Yang">{{Cite journal | last = Yang | first = J. | authorlink =  | author2 = Liao, M. | author3 = Shou, M. | author4 = Jamei, M. | author5 = Yeo, K. R. | author6 = Tucker, G. T. | author7 = Rostami-Hodjegan, A. | title = Cytochrome P450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions | journal = Current Drug Metabolism | volume = 9 | issue = 5 | pages = 384–393 | publisher = [[Bentham_Science_Publishers|Bentham]] | location =  | date = 2008-06-01 | url = http://www.ingentaconnect.com/content/ben/cdm/2008/00000009/00000005/art00004 | doi = 10.2174/138920008784746382 | pmid = 18537575 | accessdate = 2010-12-20 | archive-date = 2012-10-23 | archive-url = https://web.archive.org/web/20121023203158/http://www.ingentaconnect.com/content/ben/cdm/2008/00000009/00000005/art00004 | dead-url = no }}</ref>
<!--
Estimates of the [[protein_turnover|turnover]] rate of human CYP3A4 vary widely. For hepatic CYP3A4, ''in vivo'' methods yield estimates of enzyme [[Biological_half-life|half-life]] mainly in the range of 70 to 140 hours, whereas ''in vitro'' methods give estimates from 26 to 79 hours.<ref name = "Yang"/> Turnover of gut CYP3A4 is likely to be a function of the rate of [[enterocyte|enterocyte]] [[cell_cycle|renewal]]; an indirect approach based on recovery of activity following exposure to grapefruit juice yields measurements in the 12 to 33 hour range.<ref name = "Yang">{{Cite journal
  | last = Yang | first = J.  | authorlink =
  |author2=Liao, M. |author3=Shou, M. |author4=Jamei, M. |author5=Yeo, K. R. |author6=Tucker, G. T. |author7= Rostami-Hodjegan, A. 
  | title = Cytochrome P450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions
  | journal = Current Drug Metabolism | volume = 9 | issue = 5 | pages = 384–393
  | publisher = [[Bentham_Science_Publishers|Bentham]] | location =  | date = 2008-06-01
  | url = http://www.ingentaconnect.com/content/ben/cdm/2008/00000009/00000005/art00004| doi =  10.2174/138920008784746382| pmid = 18537575 | accessdate = 2010-12-20}}</ref>
-->

==相互作用通路图==
{{IrinotecanPathway_WP229|highlight=CYP3A4}}

==参考文献==
{{NLM content}}
{{Reflist|35em}}

==参见==
*{{le|CYP3A|CYP3A}}

==外部链接==
{{Portal|生物學|border=no}}
* [https://web.archive.org/web/20100415232522/http://www.pharmgkb.org/search/annotatedGene/cyp3a4/index.jsp PharmGKB: Annotated PGx Gene Information for CYP3A4]
* [https://web.archive.org/web/20110215024307/http://p450.althotas.com/ CYP3A4 substrate prediction]
* {{UCSC gene info|CYP3A4}}
* {{PDBe-KB2|P08684|Cytochrome P450 3A4}}

{{PDB Gallery|geneid=1576}}
{{Cytochrome P450}}
{{Dioxygenases}}
{{Enzymes}}

[[Category:细胞色素P450|3]]